Evidence map›Paper›PMID 33303068›Full record

ArticleJournal of the American College of Cardiology2020

Impact of Plaque Burden Versus Stenosis on Ischemic Events in Patients With Coronary Atherosclerosis.

Martin Bødtker Mortensen, Omar Dzaye, Flemming Hald Steffensen, Hans Erik Bøtker, Jesper Møller Jensen, Niels Peter Rønnow Sand, Kristian Hay Kragholm, Henrik Toft Sørensen, Jonathon Leipsic, Michael Mæng and 2 more

2 registry-linked trialsAbstract readComparative Study
PubMed Publisher
In one paragraph

Article in Journal of the American College of Cardiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 129 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
129citing papers in PubMed, 2 pooled it
31.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05998525 phase3completedstarted 2021, after this paper: background citation

Dapagliflozin Effects on Coronary Calcium and Epicardial Fat Assessed by Cardiotomography

Ran2021Enrolled54Registered outcomes6Posted comparisons0ConditionsDiabetes Mellitus, Type 2, Diabete Type 2, Myocardial Infarction, Unstable AnginaArmsDapagliflozin 10mg Tab, Placebo
Open the trial in the graph
NCT06520904 phase4recruitingstarted 2024, after this paper: background citation

Effect of PCSK9 Inhibitors on Coronary Atherosclerotic Plaques Derived From Optical Coherence Tomography in Patients With Premature Coronary Artery Disease: a Randomized Controlled Trial

Ran2024Enrolled396Registered outcomes6Posted comparisons0ConditionsCoronary Artery Disease, Optical Coherence TomographyArmsPCSK9 inhibitor, Statin
Open the trial in the graph
3 · Its place in the literature

Who cites it

129 citing papers in PubMed, 2 syntheses or guidelines pooled it, 262 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article

69 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

Martin Bødtker MortensenDepartment of Cardiology, Aarhus University Hospital, Aarhus, Denmark; Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Electronic address: martin.bodtker.mortensen@clin.au.dk.
Omar DzayeJohns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Flemming Hald SteffensenDepartment of Cardiology, Lillebaelt Hospital-Vejle, Vejle, Denmark.
Hans Erik BøtkerDepartment of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
Jesper Møller JensenDepartment of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
Niels Peter Rønnow SandDepartment of Cardiology, University Hospital of Southwest Jutland and Institute of Regional Health Research, University of Southern Denmark, Esbjerg, Denmark.
Kristian Hay KragholmDepartment of Cardiology, Aalborg University Hospital, Aalborg, Denmark.
Henrik Toft SørensenDepartment of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
Jonathon LeipsicSt Pauls Hospital, UBC, Vancouver, British Columbia, Canada.
Michael MængDepartment of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
Michael J BlahaJohns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Bjarne Linde NørgaardDepartment of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
Aarhus University Hospital · DKJohns Hopkins University · USAalborg University Hospital · DKLillebaelt Hospital · DKSt. Paul's Hospital · CAUniversity of Southern Denmark · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatients with obstructive coronary artery disease (CAD) are at high risk for cardiovascular disease (CVD) events. However, it remains unclear whether the high risk is due to high atherosclerotic disease burden or if presence of stenosis has independent predictive value.

objectivesThe purpose of this study was to evaluate if obstructive CAD provides predictive value beyond its association with total calcified atherosclerotic plaque burden as assessed by coronary artery calcium (CAC).

methodsAmong 23,759 symptomatic patients from the Western Denmark Heart Registry who underwent diagnostic computed tomography angiography (CTA), we assessed the risk of major CVD (myocardial infarction, stroke, and all-cause death) stratified by CAC burden and number of vessels with obstructive disease.

resultsDuring a median follow-up of 4.3 years, 1,054 patients experienced a first major CVD event. The event rate increased stepwise with both higher CAC scores and number of vessels with obstructive disease (by CAC scores: 6.2 per 1,000 person-years (PY) for CAC = 0 to 42.3 per 1,000 PY for CAC >1,000; by number of vessels with obstructive disease: 6.1 per 1,000 PY for no CAD to 34.7 per 1,000 PY for 3-vessel disease). When stratified by 5 groups of CAC scores (0, 1 to 99, 100 to 399, 400 to 1,000, and >1,000), the presence of obstructive CAD was not associated with higher risk than presence of nonobstructive CAD.

conclusionsPlaque burden, not stenosis per se, is the main predictor of risk for CVD events and death. Thus, patients with a comparable calcified atherosclerosis burden generally carry a similar risk for CVD events regardless of whether they have nonobstructive or obstructive CAD.

Indexed as

RegistriesAgedCoronary AngiographyCoronary Artery DiseaseCoronary OcclusionDenmarkFemaleFollow-Up StudiesHumansMaleMiddle AgedPlaque, Atheroscleroticcardiovascular disease riskcohort studycomputed tomography angiographycoronary artery calciumcoronary artery diseaseepidemiologyobstructive vessel disease

Identifiers

PMID33303068
OpenAlexW3113208209

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.